留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Genomic sequencing as a key primary recommendation for neonatal hyperbilirubinemia: a population-based multicenter study

Dabin Huang,  Xia Gu,  Weizhong Li,  Hongying Mi,  Haiquan Zeng,  Guiying Zhuang,  Sitao Li,  Congcong Shi,  Tao Wei,  Wei Zhou,  Xin Xiao,  Wenhao Zhou,  Hu Hao

downloadPDF
文章导航 > Journal of Genetics and Genomics  > 2025 > 优先出版
Dabin Huang, Xia Gu, Weizhong Li, Hongying Mi, Haiquan Zeng, Guiying Zhuang, Sitao Li, Congcong Shi, Tao Wei, Wei Zhou, Xin Xiao, Wenhao Zhou, Hu Hao. Genomic sequencing as a key primary recommendation for neonatal hyperbilirubinemia: a population-based multicenter study[J]. 遗传学报. doi: 10.1016/j.jgg.2025.09.002
引用本文: Dabin Huang, Xia Gu, Weizhong Li, Hongying Mi, Haiquan Zeng, Guiying Zhuang, Sitao Li, Congcong Shi, Tao Wei, Wei Zhou, Xin Xiao, Wenhao Zhou, Hu Hao. Genomic sequencing as a key primary recommendation for neonatal hyperbilirubinemia: a population-based multicenter study[J]. 遗传学报. doi: 10.1016/j.jgg.2025.09.002
shu
Dabin Huang, Xia Gu, Weizhong Li, Hongying Mi, Haiquan Zeng, Guiying Zhuang, Sitao Li, Congcong Shi, Tao Wei, Wei Zhou, Xin Xiao, Wenhao Zhou, Hu Hao. Genomic sequencing as a key primary recommendation for neonatal hyperbilirubinemia: a population-based multicenter study[J]. Journal of Genetics and Genomics. doi: 10.1016/j.jgg.2025.09.002
Citation: Dabin Huang, Xia Gu, Weizhong Li, Hongying Mi, Haiquan Zeng, Guiying Zhuang, Sitao Li, Congcong Shi, Tao Wei, Wei Zhou, Xin Xiao, Wenhao Zhou, Hu Hao. Genomic sequencing as a key primary recommendation for neonatal hyperbilirubinemia: a population-based multicenter study[J]. Journal of Genetics and Genomics. doi: 10.1016/j.jgg.2025.09.002
shu

Genomic sequencing as a key primary recommendation for neonatal hyperbilirubinemia: a population-based multicenter study

doi: 10.1016/j.jgg.2025.09.002

  • a. Department of Pediatrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China;

  • b. Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong 510655, China;

  • c. Department of Neonatology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China;

  • d. Inborn Errors of Metabolism Laboratory, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China;

  • e. Department of Neonatology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China;

  • f. Department of Pediatrics, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, China;

  • g. Department of Neonatology, Maternal and Child Health Hospital of Qingyuan City, Qingyuan, Guangdong 511500, China;

  • h. Department of Neonatology, The Maternal and Child Health Care Hospital of Huadu, Guangzhou, Guangdong 510800, China;

  • i. Department of Bioengineering, College of Food Science, South China Agricultural University, Guangzhou, Guangdong 510642, China;

  • j. Department of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China

基金项目: 

This work was supported by the Guangzhou Science and Technology Plan Project (2024B03J0191) to Hu Hao, and the Research Projects of the Sixth Affiliated Hospital, Sun Yat-sen University (No.2023-053 and No.2023-063) to Hu Hao.

详细信息
    通讯作者:

    Xin Xiao,E-mail:xiaoxin2@mail.sysu.edu.cn

    Wenhao Zhou,E-mail:zhouwenhao@fudan.edu.cn

    Hu Hao,E-mail:haohu@mail.sysu.edu.cn

Genomic sequencing as a key primary recommendation for neonatal hyperbilirubinemia: a population-based multicenter study

  • a. Department of Pediatrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China;

  • b. Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong 510655, China;

  • c. Department of Neonatology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China;

  • d. Inborn Errors of Metabolism Laboratory, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China;

  • e. Department of Neonatology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China;

  • f. Department of Pediatrics, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, China;

  • g. Department of Neonatology, Maternal and Child Health Hospital of Qingyuan City, Qingyuan, Guangdong 511500, China;

  • h. Department of Neonatology, The Maternal and Child Health Care Hospital of Huadu, Guangzhou, Guangdong 510800, China;

  • i. Department of Bioengineering, College of Food Science, South China Agricultural University, Guangzhou, Guangdong 510642, China;

  • j. Department of Neonatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China

Funds: 

This work was supported by the Guangzhou Science and Technology Plan Project (2024B03J0191) to Hu Hao, and the Research Projects of the Sixth Affiliated Hospital, Sun Yat-sen University (No.2023-053 and No.2023-063) to Hu Hao.

    摘要
  • 摘要: Genetic variations are risk factors for neonatal hyperbilirubinemia (NHB), a common cause of infant hospitalization in the first postnatal week, but their contribution and long-term impacts remain unclear. This population-based multicenter study enrolls 1,780 hospitalized NHB newborns and 38,158 genetically screened newborns across 20 hospitals (2019–2022). Excluding cases with clear clinical causes, 977 NHB cases are categorized into genetic variation-positive and -negative groups. Results show significantly higher NHB-related gene variants (81.63% vs. 65.62%) and positive variation rates (36.29% vs. 9.4%) in NHB cases than in the general newborn population (all P < 0.001). Among the 977 NHB cases, 325 (33.3%) have positive variants, with higher rates of severe hyperbilirubinemia (16.9% vs. 9.7%, P = 0.001), prolonged jaundice (36.3% vs. 27.6%, P = 0.005), and cholestasis/hypercholanaemia (23.7% vs. 14.7%, P < 0.001) in the positive group. Cumulative genetic variants in bilirubin metabolism pathways exhibit dose-dependent associations with increased risks of complications. Long-term follow-up reveals that UGT1A1 variants prolong jaundice up to 1 month, while severe SLC10A1 variants cause persistent cholestasis/hypercholanaemia beyond 9 months. This large-scale evidence highlights genetic factors as key NHB determinants, with implications for neonatal care protocols to integrate genetic testing and establish long-term surveillance for variant carriers.
    Abstract: Genetic variations are risk factors for neonatal hyperbilirubinemia (NHB), a common cause of infant hospitalization in the first postnatal week, but their contribution and long-term impacts remain unclear. This population-based multicenter study enrolls 1,780 hospitalized NHB newborns and 38,158 genetically screened newborns across 20 hospitals (2019–2022). Excluding cases with clear clinical causes, 977 NHB cases are categorized into genetic variation-positive and -negative groups. Results show significantly higher NHB-related gene variants (81.63% vs. 65.62%) and positive variation rates (36.29% vs. 9.4%) in NHB cases than in the general newborn population (all P < 0.001). Among the 977 NHB cases, 325 (33.3%) have positive variants, with higher rates of severe hyperbilirubinemia (16.9% vs. 9.7%, P = 0.001), prolonged jaundice (36.3% vs. 27.6%, P = 0.005), and cholestasis/hypercholanaemia (23.7% vs. 14.7%, P < 0.001) in the positive group. Cumulative genetic variants in bilirubin metabolism pathways exhibit dose-dependent associations with increased risks of complications. Long-term follow-up reveals that UGT1A1 variants prolong jaundice up to 1 month, while severe SLC10A1 variants cause persistent cholestasis/hypercholanaemia beyond 9 months. This large-scale evidence highlights genetic factors as key NHB determinants, with implications for neonatal care protocols to integrate genetic testing and establish long-term surveillance for variant carriers.
    • HTML全文
    • 参考文献(44)
  • Atasilp, C., Kanjanapipak, J., Vichayaprasertkul, J., Jinda, P., Tiyasirichokchai, R., Srisawasdi, P., Prempunpong, C., Chamnanphon, M., Puangpetch, A., Vanwong, N., et al., 2022. Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population. BMC Pediatr. 22, 243.
    Bancone, G., Gornsawun, G., Peerawaranun, P., Penpitchaporn, P., Paw, M.K., Poe, D.D., Win, D., Cicelia, N., Mukaka, M., Archasuksan, L., et al., 2022. Contribution of genetic factors to high rates of neonatal hyperbilirubinaemia on the Thailand-Myanmar border. PLOS Glob. Publ. Hlth. 2, e0000475.
    Chen, H.L., Wu, S.H., Hsu, S.H., Liou, B.Y., Chen, H.L., Chang, M.H., 2018. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. J. Biomed. Sci. 25, 75.
    Chen, T., Fan, C., Huang, Y., Feng, J., Zhang, Y., Miao, J., Wang, X., Li, Y., Huang, C., Jin, W., et al., 2023. Genomic sequencing as a first-tier screening test and outcomes of newborn screening. JAMA Netw. Open 6, e2331162.
    Christensen, R., Nussenzveig, R., Eldridge, B., Agarwal, A., Yaish, H., 2015. Prolonged phototherapy needed for a neonate with four mutations in genes involved in bilirubin production and metabolism. J. Neonat-perinat. Med. 8, 67-70.
    Erdeve, O., Okulu, E., Olukman, O., Ulubas, D., Buyukkale, G., Narter, F., Tunc, G., Atasay, B., Gultekin, N.D., Arsan, S., et al., 2018. The Turkish neonatal jaundice online registry: a national root cause analysis. PLOS One 13, e0193108.
    Fawaz, R., Baumann, U., Ekong, U., Fischler, B., Hadzic, N., Mack, C.L., McLin, V.A., Molleston, J.P., Neimark, E., Ng, V.L., et al., 2017. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastr. Nutr. 64, 154-168.
    Huang, C.S., 2005. Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese. J. Biomed. Sci. 12, 445-450.
    Huang, C.S., Chang, P.F., Huang, M.J., Chen, E.S., Chen, W.C., 2002. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia. Gastroenterology 123, 127-133.
    Huang, Y.S., Chang, T.E., Perng, C.L., Huang, Y.H., 2021. The association of transporter ABCC2 (MRP2) genetic variation and drug-induced hyperbilirubinemia. J. Chin. Med. Assoc. 84, 129-135.
    Kaplan, M., Renbaum, P., Vreman, H.J., Wong, R.J., Levy-Lahad, E., Hammerman, C., Stevenson, D.K., 2007. (TA)n UGT1A1 promoter polymorphism: a crucial factor in the pathophysiology of jaundice in G6PD deficient neonates. Pediatr. Res. 61, 727-731.
    Kemper, A.R., Newman, T.B., Slaughter, J.L., Maisels, M.J., Watchko, J.F., Downs, S.M., Grout, R.W., Bundy, D.G., Stark, A.R., Bogen, D.L., et al., 2022. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 150, e2022058859.
    Kingsmore, S.F., Smith, L.D., Kunard, C.M., Bainbridge, M., Batalov, S., Benson, W., Blincow, E., Caylor, S., Chambers, C., Del Angel, G., et al., 2022. A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases. Am. J. Hum. Genet. 109, 1605-1619.
    Lee, H.Y., Ithnin, A., Azma, R.Z., Othman, A., Salvador, A., Cheah, F.C., 2022. Glucose-6-Phosphate dehydrogenase deficiency and neonatal hyperbilirubinemia: insights on pathophysiology, diagnosis, and gene variants in disease heterogeneity. Front. Pediatr. 10, 875877.
    Lin, F., Xu, J.X., Wu, Y.H., Chen, Z.K., Chen, M.T., Ma, Y.B., Li, J.D., Yang, L.Y., 2023. Red blood cell membrane-related gene variants and clinical risk factors in Chinese neonates with hyperbilirubinemia. Neonatology 120, 371-380.
    Lin, F., Xu, J.X., Wu, Y.H., Ma, Y.B., Yang, L.Y., 2022a. Clinical features and genetic variations of severe neonatal hyperbilirubinemia: five case reports. World J. Clin. Cases 10, 6999-7005.
    Lin, Q., Zhu, D., Chen, C., Feng, Y., Shen, F., Wu, Z., 2022b. Risk factors for neonatal hyperbilirubinemia: a systematic review and meta-analysis. Transl. Pediatr. 11, 1001-1009.
    Lin, Z., Fontaine, J., Watchko, J.F., 2008. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics 122, e156-162.
    Maisels, M.J., Bhutani, V.K., Bogen, D., Newman, T.B., Stark, A.R., Watchko, J.F., 2009. Hyperbilirubinemia in the newborn infant ≥ 35 weeks' gestation: an update with clarifications. Pediatrics 124, 1193-1198.
    McCabe, E.R.B., 2021. Newborn screening system: safety, technology, advocacy. Mol. Genet. Metab. 134, 3-7.
    Mei, H., Dong, X., Wu, B., Wang, H., Lu, Y., Hu, L., Wang, J., Cao, Y., Zhang, R., Cheng, G., et al., 2022. Clinical and genetic etiologies of neonatal unconjugated hyperbilirubinemia in the China Neonatal Genomes Project. J. Pediatr. 243, 53-60 e59.
    Muchowski, K.E., 2014. Evaluation and treatment of neonatal hyperbilirubinemia. Am. Fam. Physician 89, 873-878.
    Olusanya, B.O., Kaplan, M., Hansen, T.W.R., 2018. Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc. 2, 610-620.
    Olusanya, B.O., Slusher, T.M., 2015. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review. World J. Pediatr. 11, 293-299.
    Polkowska, G., Polkowski, W., Kudlicka, A., Wallner, G., Chrzastek-Spruch, H., 2001. Range of serum bile acid concentrations in neonates, infants, older children, and in adults. Med. Sci. Monit. 7 Suppl 1, 268-270.
    Qattea, I., Farghaly, M.A.A., Elgendy, M., Mohamed, M.A., Aly, H., 2022. Neonatal hyperbilirubinemia and bilirubin neurotoxicity in hospitalized neonates: analysis of the US database. Pediatr. Res. 91, 1662-1668.
    Ranucci, G., Della Corte, C., Alberti, D., Bondioni, M.P., Boroni, G., Calvo, P.L., Cananzi, M., Candusso, M., Clemente, M.G., D'Antiga, L., et al., 2022. Diagnostic approach to neonatal and infantile cholestasis: a position paper by the SIGENP liver disease working group. Dig. Liver Dis. 54, 40-53.
    Schneider, A.L., Kohler, H., Rothlisberger, B., Grobholz, R., McLin, V.A., 2022. Sodium taurocholate co-transporting polypeptide deficiency. Clin. Res. Hepatol. Gas. 46, 101824.
    Schutzman, D.L., Gatien, E., Ajayi, S.,Wong, R.J., 2018. Heme oxygenase-1 genetic variants and the conundrum of hyperbilirubinemia in African-American newborns. J. Perinatol. 38, 345-350.
    van der Geest, B.A.M., de Mol, M.J.S., Barendse, I.S.A., de Graaf, J.P., Bertens, L.C.M., Poley, M.J., Ista, E., Kornelisse, R.F., Reiss, I.K.M., Steegers, E.A.P., et al., 2022. Assessment, management, and incidence of neonatal jaundice in healthy neonates cared for in primary care: a prospective cohort study. Sci. Rep. 12, 14385.
    Vockley, J., Dobrowolski, S.F., Arnold, G.L., Guerrero, R.B., Derks, T.G.J., Weinstein, D.A., 2019. Complex patterns of inheritance, including synergistic heterozygosity, in inborn errors of metabolism: implications for precision medicine driven diagnosis and treatment. Mol. Genet. Metab. 128, 1-9.
    Vockley, J., Rinaldo, P., Bennett, M.J., Matern, D., Vladutiu, G.D., 2000. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol. Genet. Metab. 71, 10-18.
    Watchko, J.F., Lin, Z., 2010. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin. Fetal Neonat. M. 15, 169-175.
    Watchko, J.F., Lin, Z., Clark, R.H., Kelleher, A.S., Walker, M.W., Spitzer, A.R., Pediatrix Hyperbilirubinemia Study, G., 2009. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics 124, e868-877.
    Xiao, T., Wang, J., Wang, H., Mei, H., Dong, X., Lu, Y., Cheng, G., Wang, L., Hu, L., Lu, W., et al., 2022. Aetiology and outcomes of prolonged neonatal jaundice in tertiary centres: data from the China Neonatal Genome Project. Arch. Dis. Child-fetal. 108, 57-62.
    Xu, J.X., Lin, F., Chen, Z.K., Luo, Z.Y., Zhan, X.F., Wu, J.R., Ma, Y.B., Li, J.D., Yang, L.Y., 2021. Co-inheritance of G6PD deficiency and 211 G to a variation of UGT1A1 in neonates with hyperbilirubinemia in eastern Guangdong. BMC Pediatr. 21, 564.
    Xu, J.X., Lin, F., Wu, Y.H., Chen, Z.K., Ma, Y.B., Yang, L.Y., 2023. Etiology analysis for term newborns with severe hyperbilirubinemia in eastern Guangdong of China. World J. Clin. Cases 11, 2443-2451.
    Yang, F., Xu, W., Wu, L., Yang, L., Zhu, S., Wang, L., Wu, W., Zhang, Y., Chong, Y., Peng, L., 2022a. NTCP deficiency affects the levels of circulating bile acids and induces osteoporosis. Front. Endocrinol. 13, 898750.
    Yang, H., Wang, Q., Zheng, L., Lin, M., Zheng, X.B., Lin, F., Yang, L.Y., 2015. Multiple genetic modifiers of bilirubin metabolism involvement in significant neonatal hyperbilirubinemia in patients of chinese descent. PLOS One 10, e0132034.
    Yang, H., Wang, Q., Zheng, L., Zheng, X.B., Lin, M., Zhan, X.F., Yang, L.Y., 2016. Clinical significance of UGT1A1 genetic analysis in Chinese neonates with severe hyperbilirubinemia. Pediatr. Neonatol. 57, 310-317.
    Yang, Y., Wang, Y., Zhou, L., Long, W., Yu, B., Wang, H., 2022b. Molecular genetic screening of neonatal intensive care units: hyperbilirubinemia as an example. Appl. Clin. Genet. 15, 39-48.
    Yang, Y.K., Lin, C.F., Lin, F., Chen, Z.K., Liao, Y.W., Huang, Y.C., Xiao, B.R., Huang, S.H., Xu, Y.M., Chen, Y.E., et al., 2023. Etiology analysis and G6PD deficiency for term infants with jaundice in Yangjiang of western Guangdong. Front. Pediatr. 11, 1201940.
    Yang, Z., Lin, F., Xu, J.X., Yang, H., Wu, Y.H., Chen, Z.K., Xie, H., Huang, B., Lin, W.H., Wu, J.P., et al., 2022c. UGT1A1*6 mutation associated with the occurrence and severity in infants with prolonged jaundice. Front. Pediatr. 10, 1080212.
    Zangen, S., Kidron, D., Gelbart, T., Roy-Chowdhury, N., Wang, X., Kaplan, M., 2009. Fatal kernicterus in a girl deficient in glucose-6-phosphate dehydrogenase: a paradigm of synergistic heterozygosity. J. Pediatr. 154, 616-619.
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  25
  • HTML全文浏览量:  12
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-06-03
  • 录用日期:  2025-09-04
  • 修回日期:  2025-08-30
  • 网络出版日期:  2025-09-11

目录

    /

    返回文章
    返回

    Copyright © 2009《 石油钻探技术 》 All Rights Reserved.

    地址：北京市朝阳区北辰东路8号北辰时代大厦716室邮政编码：100101

    电话：010-84988317，84988356，84988357传真：021-64253812Email：syzt@vip.163.com

    京公网安备 11010502036328号　京ICP备17033152号

    本系统由 北京仁和汇智信息技术有限公司 开发